BioStem Technologies (OTCMKTS:BSEM) Shares Up 3.1% – Here’s Why

Shares of BioStem Technologies, Inc. (OTCMKTS:BSEM) were up 3.1% during mid-day trading on Friday . The company traded as high as $4.45 and last traded at $4.31. Approximately 142,954 shares traded hands during trading, an increase of 64% from the average session volume of 86,956 shares. The stock had previously closed at $4.18.

BioStem Technologies Trading Up 3.1%

The firm has a 50-day moving average of $3.64 and a two-hundred day moving average of $4.21. The firm has a market cap of $76.93 million, a price-to-earnings ratio of -3.87 and a beta of 0.12.

BioStem Technologies (OTCMKTS:BSEM) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.50) by ($0.02). The business had revenue of $7.90 million during the quarter, compared to the consensus estimate of $6.35 million. As a group, equities analysts anticipate that BioStem Technologies, Inc. will post -1.95 EPS for the current year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr.